Building on the success of previous years’ programs, the Hematology/Oncology Pharmacy Association’s (HOPA) 5th Annual Oncology Pharmacy Practice Management Program will be held at the Chicago Marriott O’Hare on September 15-16, 2017, and will include three new areas of interest for pharmacy practice managers.
Join experts in the field of pharmacy services management, and share expertise and practical solutions to the everyday challenges of providing top-of-the-line clinical care in a fiscally responsible manner.
The Hematology Oncology Pharmacy Association (HOPA) will convene a summit with healthcare professionals and industry members to discuss examples of oncology drug waste in the US and identify approaches to reduce the burden of drug waste on the US healthcare system. Dr. Peter Bach, director at the Center for Health Policy Outcomes at Memorial Sloan-Kettering Cancer Center, will serve as the keynote speaker.
CancerLinQ Now Combines the Expertise of Oncologists, Nurses, and Pharmacists to Improve Patient Care
The Hematology/Oncology Pharmacy Association (HOPA), in partnership with Eisai Inc. and Helsinn Therapeutics (U.S.), Inc., today announced the launch of the Time to Talk CINV™ toolkit, which is comprised of resources for patients with cancer going through chemotherapy and their healthcare providers.
The Hematology/Oncology Pharmacy Association (HOPA) applauds Senators Chuck Grassley (R-IA), Susan Collins (R-ME), Sherrod Brown (D-OH), and Bob Casey (D-PA) for introducing S. 109, the Pharmacy and Medically Underserved Areas Enhancement Act.
The Hematology/Oncology Pharmacy Association (HOPA) applauds President Obama for signing the landmark legislation, the 21st Century Cures Act into law today. After nearly 18 months of deliberation and negotiations, this new law will allow for significant advancements in the discovery and development of life-saving and life-improving therapies.
Explore significant research developments and treatment advances relevant to oncology pharmacists presented at the ASCO Annual Meeting at the Updates from the American Society of Clinical Oncology (ASCO) Annual Meeting webinar on September 29, 2016, from 12:00 – 1:00 pm CST. This is the final live presentation in the 2016 Emerging Issues in Oncology Webinar Series for Board Certified Oncology Pharmacy recertification opportunities presented by the Hematology/Oncology Pharmacy Association (HOPA).
Advanced level oncology pharmacists seeking quality educational opportunities to meet their Board Certified Oncology Pharmacy (BCOP) recertification requirements will find the highly rated Conference Programming Specialty Sessions Repeat a great option.
Explore significant research developments and treatment advances relevant to oncology pharmacists presented at the ASPHO annual meeting at the Updates from the American Society of Pediatric Hematology/Oncology (ASPHO) Annual Meeting webinar on July 14, 2016, from 12:00 – 1:00 pm CST.
Join experts in the field of pharmacy services management as they share their expertise and practical solutions to the everyday challenges of providing top-of-the-line clinical care in a fiscally responsible manner at the Hematology/Oncology Pharmacy Association (HOPA) 4th Annual HOPA Oncology Pharmacy Practice Management Program at the Chicago Marriott O’Hare on September 23-24, 2016.
Registration is now open for the all new BCOP Oncology Pharmacy Updates Course, taking place July 15-16, 2016, at the Hyatt Regency Orlando. Presented by the Hematology/Oncology Pharmacy Association (HOPA) and led by an all-star group of faculty, the Oncology Pharmacy Updates Course is a live, interactive course that will cover new and ongoing therapeutic developments that have emerged within the last three years.
The Hematology/Oncology Pharmacy Association (HOPA) has awarded two HOPA Research Grant Awards to Drs. Val Adams, PharmD BCOP FCCP and Jill S Bates, PharmD MS BCOP for their respective research projects.
The Hematology/Oncology Pharmacy Association inducted the 2016 class of Fellows of the Hematology/Oncology Pharmacy Association (FHOPA) at the recent HOPA Annual Conference.
The Hematology/Oncology Pharmacy Association (HOPA) awarded Edward D. Gormley, Jr., BS CPhT, the 2016 Technician Award at the 12th HOPA Annual Conference on March 17 in Atlanta. This award recognizes a technician who demonstrates excellence in his/her work and shows a commitment to hematology/oncology pharmacy practice in an organized health care setting.
The Hematology/Oncology Pharmacy Association (HOPA) awarded Niesha L. Griffith, MS RPh FASHP, the 2016 Award of Excellence at the 12th HOPA Annual Conference on March 17 in Atlanta. This prestigious award recognizes a member who has made a significant, sustained contribution to or provided excellent leadership in improving or supporting hematology/oncology pharmacy.
The Hematology/Oncology Pharmacy Association (HOPA) awarded Ginah Nightingale, PharmD BCOP, the 2016 Oncology Pharmacy Practice Literature Award at the 12th HOPA Annual Conference on March 17 in Atlanta. This prestigious award recognizes an article, other than scientific research, that contributes to the betterment of the hematology/oncology pharmacy profession, and describes innovations in community, hospital, or healthcare system in hematology/oncology pharmacy practices.
The Hematology/Oncology Pharmacy Association (HOPA) awarded Kristin Held Wheatley, PharmD BCOP, the 2016 New Practitioner Award at the 12th HOPA Annual Conference on March 17 in Atlanta. This prestigious award recognizes a member early in their career who has made a notable contribution to developing or supporting clinical hematology/oncology pharmacy services.
The Hematology/Oncology Pharmacy Association has elected Dr. Sarah Scarpace, PharmD MPH BCOP, to serve as President for the 2016-2017 term. Scarpace recently took office at the 12th HOPA Annual Conference held March 16-19 in Atlanta, Georgia. Scarpace has served as President-elect since March of 2015.
Edward Li, PharmD MPH BCOP, took office as an At Large Member of the Board of Directors at the recent 12th Hematology/Oncology Pharmacy Association (HOPA) Annual Conference in March.
Susannah Koontz, PharmD BCOP FHOPA, took office as President-elect of the Hematology/Oncology Pharmacy Association (HOPA) at the recent 12th HOPA Annual Conference in March. Dr. Koontz will serve as President-elect for the 2016-2017 term and assume the office of President in March of 2017.
The Hematology/Oncology Pharmacy Association (HOPA) awarded Benyam Muluneh, PharmD BCOP CPP, the 2016 Patient Advocacy Award at the 12th HOPA Annual Conference on March 17 in Atlanta. This prestigious award, supported by Teva Oncology, recognizes a HOPA member who demonstrates leadership and collaboration while advocating for outstanding patient care.
The Hematology/Oncology Pharmacy Association (HOPA) awarded Meghana V. Trivedi, Pharm.D., Ph.D., BCOP, the 2016 Basic Science and Clinical Research Literature Award at the 12th HOPA Annual Conference on March 17 in Atlanta. This prestigious award recognizes distinct articles that describe hematology/oncology basic science and/or translational research or clinical trials evaluating drug efficacy and/or safety.
Registration is open for the latest Emerging Issues in Oncology Webinar series featuring Updates from the San Antonio Breast Cancer Symposium (SABCS) on March 10 from 12:00 – 1:00 pm CST.
HOPA is kicking off its newly developed Board Certified Oncology Pharmacist (BCOP) Recertification Program with the first in a series of five Emerging Issues in Oncology Webinars.
Pulitzer Prize-winning author and oncologist, Siddhartha Mukherjee, M.D., Ph.D., will be the opening keynote speaker at the HOPA 12th Annual Conference in Atlanta, Georgia.
The Hematology/Oncology Pharmacy Association (HOPA) announces several new BCOP Recertification education opportunities to provide credit needed to ensure continued certification.
The Hematology/Oncology Pharmacy Association has elected Heidi D. Finnes, Pharm D, BCOP as a Board Member at large for the 2015-2016 term. A HOPA member since 2004, Dr. Finnes has filled leadership positions within HOPA as both the Program Committee chair and the Session Proposal Work Group chair.
The Hematology/Oncology Pharmacy Association (HOPA) will present the HOPA Oncology Pharmacy Practice Management Program at the Hilton Rosemont/Chicago O’Hare on September 18-19, 2015, in Rosemont, IL. The program will examine how to provide a high level of clinical practice when patients demand more, but front offices and third-party payers require it be done with less.
The Hematology/Oncology Pharmacy Association has elected David DeRemer, Pharm D, BCOP as a Board Member at large for the 2015-2016 term. Dr. DeRemer has been an active member of HOPA since 2006.
The Hematology/Oncology Pharmacy Association has elected Helen M. Marshall, Pharm D, BCPS, BCOP as Secretary, Member of the Board, for the 2015-2016 term. Dr. Marshall took office at the recent 11th HOPA Annual Conference in March.
The Hematology/Oncology Pharmacy Association is pleased to announce the introduction of the Fellow of the Hematology/Oncology Pharmacy Association (FHOPA) designation, recognizing excellence in oncology pharmacy. Individuals awarded will have demonstrated sustained contributions to HOPA and exceptional performance in oncology pharmacy.
Top residents, fellows, and students who specialize in hematology/oncology pharmacy were recognized at the recent Hematology/Oncology Pharmacy Association (HOPA) Annual Conference this past March for their Trainee Research in Progress submissions.
Membership Awards recognize members who have shown outstanding achievement in their field.
Dr. Scott Soefje PHARMD MBA BCOP FCCP inducted 2015-2016 President of the Hematology/Oncology Pharmacy Association (HOPA) at recent 11th Annual Conference.
HOPA recommends a naming policy for biosimilars to avoid prescribing and dispensing errors as well as ensuring biosimilars are able to be easily tracked to monitor safety and quality.
The Hematology/Oncology Pharmacy Association (HOPA) has developed this short educational video to share with facilities, patients, and the public to help explain the critical role the oncology pharmacist plays on the cancer treatment healthcare team. HOPA gives permission for use in hospitals, clinics, and pharmacies nationwide.
Pharmacists have an important role in ensuring that clinical trials are conducted according to good clinical trials practices. The Hematology/Oncology Pharmacy Association has released the HOPA Investigational Drug Service Best Practice Standards, the first of its kind.
The Hematology/Oncology Pharmacy Association’s (HOPA) 2nd Annual Oncology Pharmacy Practice Management Program will be taking place at the Hyatt Regency O’Hare, September 19-20, 2014 in Rosemont, IL.
The Hematology/Oncology Pharmacy Association (HOPA) announced the recipients of the 2014 HOPA Membership Awards at its 10th Annual Conference in March.
As an integral part of the healthcare team, oncology pharmacists play an important role in the delivery of care of individuals living with cancer.
In a letter to CVS/Caremark President and CEO Larry Merlo, the Hematology/Oncology Pharmacy Association (HOPA) applauds CVS/Caremark’s decision to put public health above profits. Smoking kills almost half a million adults in the United States every year.
The Hematology/Oncology Pharmacy Association (HOPA) awards Dr. Kerry Parsons, BCOP PharmD, with the 2013 HOPA Research Award.
The Scope of Hematology/Oncology Pharmacy Practice is the first document to clearly define the knowledge, skills and functions of the hematology/oncology pharmacist, primarily related to direct patient care, and to promote a better understanding of this ever-growing profession.
The Hematology/Oncology Pharmacy Association (HOPA) has elected Niesha Griffith, RPh MS FASHP, as president of the association for the 2013-2014 year. Griffith has been a long-standing and active member in HOPA since its beginning in 2004, serving as chair of the Legislative (now Health Policy) committee, and a member of the board of directors for two years prior to her election. Griffith is a passionate advocate for oral chemotherapy parity and access to medication for cancer patients, and has played a key role in the development of HOPA’s Health Policy and Advocacy program.
The Hematology/Oncology Pharmacy Association (HOPA) is pleased to present the HOPA Oncology Pharmacy Practice Management program, taking place September 27 from 7:00 am – 7:00 pm at the Sheraton Chicago O’Hare Airport Hotel, designed to guide oncology pharmacy providers on how to effectively manage the expensive, high risk care and oncology medications they provide, but still allow for the implementation of new technologies, improvement of safety, and adhere to compliance.
The Hematology/Oncology Pharmacy Association (HOPA) has released a survey of oncology pharmacists which warns that oncology drug shortages happen often and have serious negative consequences on cancer patients in the in the United States. Published in the April 1, 2013 issue of the American Journal of Health-System Pharmacy, the survey was completed by hematology/oncology pharmacists, who care for cancer patients in all phases of treatment and are uniquely positioned to provide insight on oncology drug shortages.
The HOPA Foundation Board of Directors is pleased to announce the recipients of the 2012 HOPA Foundation Research Award, Dr. Kamakshi Rao for her project Improving & Defining the Impact & Value of Pharmacists in Stem Cell Transplant, and to Dr. Quan Li, for his project, In Vitro Stability of Erlotinib, Lapatinib and Imatinib in Common Compounding Vehicles. These research grants, totaling more than $36,000 in funding, are intended to provide support for projects that are likely to result in facilitating the efforts of hematology/oncology pharmacists to optimize the care of individuals affected by cancer.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right